Ruixin Medical's AI-Powered Robotic Interventional Solution Showcased at 2025 Medical Device Economic Information Conference, Garnering High Praise from Clinical Experts and Industry Partners
RaysightMed
Medical Imaging Product Developer
On October 21-22, the "2025 Medical Device Economic Information Release Conference," approved by the National Medical Products Administration (NMPA) and hosted by the Southern Medicine Economic Research Institute of NMPA (hereinafter referred to as "Southern Institute") and organized by the "Medical Economy News," was held in Hefei, Anhui. Chen Yan, Assistant to the General Manager of RaysightMed, was invited to attend and delivered a keynote speech titled "AI Empowering Surgical Robots, Building the Future Smart Operating Room" at the parallel release session on "Artificial Intelligence and Brain-Computer Interface." She exchanged technical and product innovation achievements with industry experts and discussed industry development trends.Received high attention and active discussion from experts and industry partners at the conference.。
The theme of this conference is "Strengthening the Chain through Technological Intelligence, Optimizing the Ecosystem via Innovative Integration, and Promoting Development by Reform Empowerment." It focuses on the interpretation of medical device policies and regulations, releases research reports on the development of the medical device industry, showcases innovative achievements in the high-end medical device industry, unites forces from all sectors of society, serves scientific regulation of medical devices, and promotes high-quality industrial development.
During the themed sharing session, Chen Yan, Assistant to the General Manager of RaysightMed, introduced,RaysightMed is committed to empowering robots with original AI technology, building a full-cycle cardiovascular intelligent diagnosis and treatment system covering "pre-operation, intra-operation, and post-operation."。
Preoperatively, AI is not just about image processing; RuiXin-FFR, based on coronary CT imaging, achieves non-invasive and precise coronary functional assessment.Accurate Screening of Myocardial Ischemia and Support for Preoperative Planning of Virtual Stenting, Assisting in the Development of Cardiovascular Intervention or Bypass Surgery Plans。
During the surgery, RaysightMed utilizes surgical robots to create intelligent operating rooms. AngioQFA, based on coronary angiography images during the procedure, synchronously outputs FFR (Fractional Flow Reserve), IMR (Index of Microcirculatory Resistance), and QCA (Quantitative Coronary Angiography) values within 10 seconds. Through "morphological + functional" dual assessment, it provides real-time guidance for stent size and position selection. The fully automatic AI vascular interventional surgical robot, driven by the doctor's voice commands, enables AI to perform intelligent perception, decision-making, and execution, completing cardiovascular interventional surgeries.
Post-surgery, RaysightMed has developed a systematic health management solution that enables patient follow-up and cardiac rehabilitation management. Through dual morphological and functional assessments, it predicts the possibility of in-stent restenosis.
RaysightMed's AI + Robotics Intelligent Diagnosis and Treatment Solution Demonstrates Its Innovative Strength and Technical Leadership in the Field of Cardiovascular Precision MedicineIn the future, RaysightMed will continue to focus on the field of cardiovascular precision diagnosis and treatment, drive product innovation with original technology, collaborate with clinical experts and industry partners, jointly promote the construction and popularization of smart operating rooms, and bring more efficient and precise intelligent solutions for the diagnosis and treatment of cardiovascular diseases worldwide.
